Beta Drugs IPO — Listing Performance
Beta Drugs IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 29 Sep 2017 |
| Listing date | 12 Oct 2017 |
| Issue price | ₹85 |
| Listing-day close | ₹101.95 (19.94%) |
| Recent market price | ₹2,118.50 (2392.35% vs issue) |
| 52-week range | ₹339 – ₹2,668.30 |
| Identifiers | NSE: BETA · ISIN: INE351Y01019 |
How the listing went
Beta Drugs saw a healthy listing pop, closing day one 19.94% above the issue price.
Beta Drugs against every other debut on record
- Rank in 2017: 24 of 63 NSE debuts, on a 19.94% first-day close.
- 70th percentile of 28 SME debuts in 2017 (median 6.63%).
- 6th of 16 debuts in October 2017.
- Opened 20% above issue, then gave up 0.06 points to the close.
- Day-one range ₹92 to ₹102: a 11.76% swing on the issue price.
- Last close ₹2,118.50 (11 Sep 2026): 2392.35% above issue, against 19.94% on day one.
- 76% up its 52-week range of ₹339 to ₹2,668.30.
- Listed 8 calendar days after close.
- All 601 SME debuts on record: median 14.22%, 79% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources